I founded Scientific Intake to provide an entirely new, effective tool for weight management. Our initial clinical study proved that slowing food intake and increasing oral processing with our device at the gateway to the body resulted in users being satisfied on 23% less food. More trials followed and published independent studies showed that slower eating allowed time for secretions of natural hunger and satiety metabolic hormones like GLP-1 to signal fullness to the brain. We refined our device, invented an embedded sensor to monitor usage and progress to goal weight, facilitate coaching, and expanded our patents. Ultimately, FDA market clearance was achieved, (De Novo , Non-Significant Risk designation). The introduction of the synthetic GLP-1 drug, semaglutide, changed everything. Healthcare professionals, the media and the public were educated that there was finally a viable solution to the world's number one healthcare problem- and the mechanism of action depends on metabolic hormones, the same as Scientific Intake’s SmartByte device. Our objective now is to find a company with the funds and expertise to bring our safe and affordable pharma alternative to the world so more people can benefit from metabolic hormone based weight management.